What Are The Recommended Guidelines For Combining Fractional Laser Resurfacing With Injectable Fillers And Neurotoxins In The Same Session? Key Sequencing Strategies For Safe And Effective Results

The safest default is to sequence injectables carefully rather than treat them as interchangeable. Based on the supplied protocol, deep dermal fillers may be placed immediately before fractional laser treatment, provided the laser’s ablation channels will not reach the filler. Neurotoxins should be injected first, with at least a 30-minute interval before laser application; injecting neurotoxin immediately after laser ablation is not recommended. Final sequencing should account for the laser type, treatment depth, filler plane, injection sites, and the product manufacturer’s guidance.

Core takeaway: Same-session treatment can be appropriate, but it requires strict control of depth, timing, and tissue manipulation. When there is uncertainty—especially with ablative or deeply penetrating laser settings—separating the procedures is the more conservative option.

Why Treatment Sequencing Matters

Each treatment targets a different aging mechanism

Fractional laser resurfacing addresses superficial photoaging, texture irregularity, fine lines, pigmentation, and dermal remodeling.

Dermal fillers restore volume and structural support, while neurotoxins reduce dynamic wrinkles by temporarily weakening targeted muscles.

Combining them can address surface damage, volume loss, and muscle activity in one treatment plan.

Heat and edema can affect injectable placement

Laser treatment produces localized thermal injury and, depending on the device, ablation and tissue edema.

These effects may be clinically important when the laser is performed near freshly injected material or when post-laser swelling could alter the distribution of a neurotoxin.

Recommended Same-Session Sequence

Place neurotoxin before the laser

The supplied protocol recommends administering neurotoxin before fractional laser treatment and allowing a minimum interval of 30 minutes before applying the laser.

This interval helps separate the injection event from subsequent laser-induced edema and tissue manipulation.

Avoid neurotoxin immediately after laser ablation

Neurotoxin injection immediately after fractional laser ablation is not recommended.

Laser-induced edema may increase unwanted diffusion from the injection site, potentially causing asymmetric facial weakness or other unintended muscle effects.

Place filler before laser only under defined conditions

Dermal filler may be administered immediately before laser treatment when the filler is placed deep enough to remain beyond the reach of the laser’s ablation channels.

This is not a universal rule. The clinician must compare the filler plane with the laser’s expected depth and treatment parameters.

Use a laser-first approach when depth or heat exposure is uncertain

Several supplementary protocols favor completing energy-based treatment before filler injection to reduce concerns about heat exposure, displacement, or manipulation of freshly placed filler.

Therefore, if the laser is ablative, aggressive, deeply penetrating, or being used close to the filler site, laser first and filler later—or separate treatment days—may be the more conservative approach.

How to Apply the Protocol by Injectable Type

Neurotoxins

Inject before the fractional laser.
Allow at least 30 minutes before laser application.
Avoid injecting immediately after laser ablation.
Use careful site selection and minimize unnecessary manipulation after injection.

Dermal fillers

Same-session treatment may be considered when the filler is placed in a deeper tissue plane than the laser’s effective ablation depth.
Confirm that the laser will not directly treat over or near the injected filler in a way that could create excessive thermal exposure.
For superficial filler placement, uncertain planes, or aggressive laser settings, consider performing the laser first or staging the treatments.

Combination treatment areas

Extra caution is warranted when the laser and injections involve the same anatomic region, particularly around thin-skinned or highly mobile areas.

The treatment plan should specify the injection plane, laser depth, energy settings, treatment overlap, and expected degree of postoperative swelling.

Understanding the Trade-offs

Same-session treatment improves convenience

Combining procedures can reduce the number of visits and address multiple contributors to facial aging at once.

It may also create a more comprehensive result by treating dynamic lines, volume loss, and skin quality together.

Staged treatment offers greater control

Separating procedures can make it easier to assess swelling, bruising, filler placement, and neurotoxin effects before performing the next intervention.

This is especially useful for patients receiving ablative fractional CO₂ or Er:YAG treatment, high-energy settings, or injections near the laser field.

Evidence is not uniform across all devices

The phrase “fractional laser” covers substantially different technologies, including non-ablative systems and ablative CO₂ or Er:YAG devices.

Findings from a non-ablative laser protocol should not automatically be applied to an aggressive ablative treatment. Device-specific instructions and clinical judgment remain essential.

Common Pitfalls to Avoid

Treating all fillers as if they occupy the same depth

Filler may be placed superficially, subdermally, supraperiosteally, or in other tissue planes.

The relevant question is not simply whether filler is being used, but whether its actual placement depth overlaps the laser’s treatment zone.

Assuming more swelling is harmless

Post-laser edema can obscure early assessment and may affect the apparent symmetry of neurotoxin-treated muscles.

Patients should be counseled that swelling can temporarily alter appearance and that unexpected weakness or asymmetry requires clinical review.

Ignoring product and device instructions

Filler manufacturers, neurotoxin manufacturers, and laser manufacturers may provide different precautions.

The treating clinician should follow the most specific applicable instructions, particularly for ablative devices, combination treatments, and treatment over recently injected areas.

Applying one sequence to every patient

The correct sequence depends on the treatment objective, injection location, filler plane, laser type, energy level, skin condition, and the clinician’s experience.

A standardized sequence is useful, but it should not replace individualized planning.

How to Apply This to Your Project

The final protocol should be confirmed by a qualified clinician who knows the exact devices, products, injection planes, and settings involved.

If your primary focus is same-day convenience: Inject neurotoxin first, wait at least 30 minutes, and consider filler before laser only when it is demonstrably deeper than the laser’s ablation zone.
If your primary focus is maximum procedural conservatism: Perform the laser first and stage filler, particularly when using aggressive ablative settings or when filler depth and thermal exposure are uncertain.
If your primary focus is minimizing neurotoxin diffusion: Do not inject neurotoxin immediately after laser ablation, and allow the recommended pre-laser interval.
If your primary focus is treating a shared anatomic area: Review the injection plane and laser depth together before deciding whether same-session treatment is appropriate.

The safest combination protocol is the one that matches injection depth and timing to the specific laser’s tissue effects, rather than relying on a universal sequence.

Summary Table:

Treatment	Recommended Timing	Key Considerations
Neurotoxin	Before laser, with ≥30-minute interval	Avoid injecting immediately after laser to prevent diffusion and asymmetry
Deep filler	May be placed immediately before laser if filler plane is deeper than laser ablation depth	Confirm depth to avoid thermal interaction
Superficial filler or uncertain depth	Laser first, then filler (possibly staged)	Avoid thermal exposure and displacement
Ablative laser (CO₂, Er:YAG)	More conservative: stage procedures	Higher thermal effects require greater caution

Ensure your patients get the safest and most effective combination treatments. BELIS offers professional-grade aesthetic devices including fractional lasers (CO₂, Er:YAG) and advanced injectable-compatible technologies. Our team of experts can guide you on protocol integration and device selection. Contact us today to learn more!